Affordable Access

BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay.

Authors
  • Vela Navarrete, R
  • Garcia Cardoso, J V
  • Barat, A
  • Manzarbeitia, F
  • López Farré, A
Type
Published Article
Journal
European urology
Publication Date
Nov 01, 2003
Volume
44
Issue
5
Pages
549–555
Identifiers
PMID: 14572753
Source
Medline
License
Unknown

Abstract

The BPH inflammatory hypothesis was tested in humans. Our pilot study shows a significant reduction of some inflammatory parameters in prostatic tissues of patients treated with Permixon. These biological findings justify a pharmacological effect of this drug on the inflammatory status of the adenoma. A correlation with clinical improvement was observed.

Report this publication

Statistics

Seen <100 times